The Journal of Pediatrics
Volume 157, Issue 3 , Pages 381-387.e1 , September 2010

Early Surgical Ligation Versus a Conservative Approach for Management of Patent Ductus Arteriosus That Fails to Close after Indomethacin Treatment

  • Nami Jhaveri, MD

      Affiliations

    • Department of Pediatrics, University of California, San Francisco, CA
    • ,
  • Anita Moon-Grady, MD

      Affiliations

    • Department of Pediatrics, University of California, San Francisco, CA
    • ,
  • Ronald I. Clyman, MD

      Affiliations

    • Department of Pediatrics, University of California, San Francisco, CA
    • Cardiovascular Research Institute, University of California, San Francisco, CA
    • Corresponding Author InformationReprint requests: Ronald I. Clyman, MD, Box 0544, HSW 1408,University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143-0544.

Received 29 December 2009 ,Revised 11 February 2010 ,Accepted 25 February 2010.

References 

  1. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2002;CD000174
  2. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994;93:543–550
  3. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344:1966–1972
  4. Bandstra ES, Montalvo BM, Goldberg RN, Pacheco I, Ferrer PL, Flynn J, et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics. 1988;82:533–542
  5. Al Faleh K, Smyth J, Roberts R, Solimano A, Asztalos E, Schmidt B. Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. Pediatrics. 2008;121:e233–e238
  6. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant treated infants <1250 grams. [Abstract] Pediatr Res. 1994;35:331
  7. Clyman RI, Chorne N. PDA treatment: Effects on pulmonary hemorrhage and pulmonary morbidity. J Pediatr. 2008;152:447–448
  8. Kaapa P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand. 1983;72:179–184
  9. Cotton RB, Stahlman MT, Berder HW, Graham TP, Catterton WZ, Kover I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr. 1978;93:647–651
  10. Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed. 2007;92:F498–F502
  11. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Jonier CH, Godoy G, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med. 1989;320:1511–1516
  12. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr. 2005;40:184–188
  13. Sankaran K, Puckett B, Lee DS, Seshia M, Boulton J, Qiu Z, et al. Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr. 2004;39:366–372
  14. Roclawski M, Sabiniewicz R, Potaz P, Smoczynski A, Pankowski R, Mazurek T, et al. Scoliosis in patients with aortic coarctation and patent ductus arteriosus: does standard posterolateral thoracotomy play a role in the development of the lateral curve of the spine?. Pediatr Cardiol. 2009;30:941–945
  15. Smith ME, King JD, Elsherif A, Muntz HR, Park AH, Kouretas PC. Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility?. Laryngoscope. 2009;119:1606–1609
  16. Clement WA, El-Hakim H, Phillipos EZ, Cote JJ. Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg. 2008;134:28–33
  17. Moin F, Kennedy KA, Moya FR. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol. 2003;20:313–320
  18. Clyman R, Cassady G, Kirklin JK, Collins M, Philips JB. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr. 2009;154:873–876
  19. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007;119:1165–1174
  20. McCurnin DC, Yoder BA, Coalson J, Grubb P, Kerecman J, Kupferschmid J, et al. Effect of ductus ligation on cardiopulmonary function in premature baboons. Am J Respir Crit Care Med. 2005;172:1569–1574
  21. Chang LY, McCurnin D, Yoder B, Clyman R. Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res. 2008;63:299–302
  22. Jhaveri N, Soll RF, Clyman RI. Patent ductus arteriosus: Feeding practices and PDA ligation preferences: are they related? Am J Perinatology, 2010 Mar 11. [Epub ahead of print].
  23. Keller RL, Clyman RI. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics. 2003;112:583–587
  24. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7
  25. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al. The incidence and course of retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity Study. Pediatrics. 2005;116:15–23
  26. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight < 1500 grams. J Pediatr. 1978;92:529–534
  27. Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV, Clyman RI. Combined treatment with a non-selective nitric oxide synthase inhibitor (L-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res. 2005;58:1216–1221
  28. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr. 2005;147:38–42
  29. Suzumura H, Nitta A, Tanaka G, Arisaka O. Diastolic flow velocity of the left pulmonary artery of patent ductus arteriosus in preterm infants. Pediatr Int. 2001;43:146–151
  30. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed. 2005;90:F419–F422
  31. Evans N, Iyer P. Assessment of ductus arteriosus shunt in preterm infants supported by mechanical ventilation: effect of interatrial shunting. J Pediatr. 1994;125:778–785
  32. Gerhardt T, Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate. 1980;38:96–105
  33. Johnson DS, Rogers JH, Null DM, DeLemos RA. The physiologic consequences of the ductus arteriosus in the extremely immature newborn. [Abstract] Clin Res. 1978;26:826
  34. Naulty CM, Horn S, Conry J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr. 1978;93:682–684
  35. Szymankiewicz M, Hodgman JE, Siassi B, Gadzinowski J. Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonate. 2004;85:32–36
  36. Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr. 1994;125:270–277
  37. Meyers R, Alpan G, Clyman RI. Effect of patent ductus arteriosus and indomethacin on intestinal blood flow in the newborn lamb. Pediatr Res. 1991;29:569–574
  38. McCurnin D, Clyman RI. Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. Pediatrics. 2008;122:e1262–e1267
  39. Hans DM, Pylipow M, Long JD, Thureen PJ, Georgieff MK. Nutritional practices in the neonatal intensive care unit: analysis of a 2006 neonatal nutrition survey. Pediatrics. 2009;123:51–57
  40. Teixeira LS, Shivananda SP, Stephens D, Van Arsdell G, McNamara PJ. Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol. 2008;28:803–810
  41. Bhat R, Fisher E, Raju TN, Vidyasagar D. Patent ductus arteriosus: recent advances in diagnosis and management. Pediatr Clin North Am. 1982;29:1117–1136

 Supported in part by grants from the US Public Health Service (Grants NHLBI HL46691 and NIH/NCRR UCSF-CTSI UL1 RR024131) and a gift from the Jamie and Bobby Gates Foundation. R.C. received a research grant from Ovation Pharmaceuticals, Inc. The other authors declare no conflicts of interest.

PII: S0022-3476(10)00206-4

doi: 10.1016/j.jpeds.2010.02.062

The Journal of Pediatrics
Volume 157, Issue 3 , Pages 381-387.e1 , September 2010

Article Tools

* Image Usage & Resolution